CN Patent

CN102746285A — 作为hedgehog途径调节剂的化合物和组合物

Assigned to Sun Pharmaceutical Industries Ltd · Expires 2012-10-24 · 14y expired

What this patent protects

本发明涉及作为HEDGEHOG途径调节剂的化合物和组合物。本发明提供了调节hedgehog信号传导途径的活性的方法。特别是，本发明提供了抑制异常生长状态的方法，所述的异常生长状态是由表型例如Ptc失功能、hedgehog获功能、smoothened获功能或Gli获功能引起的，该方法包括将细胞与足够量的式I化合物接触。

USPTO Abstract

本发明涉及作为HEDGEHOG途径调节剂的化合物和组合物。本发明提供了调节hedgehog信号传导途径的活性的方法。特别是，本发明提供了抑制异常生长状态的方法，所述的异常生长状态是由表型例如Ptc失功能、hedgehog获功能、smoothened获功能或Gli获功能引起的，该方法包括将细胞与足够量的式I化合物接触。

Drugs covered by this patent

Patent Metadata

Patent number
CN102746285A
Jurisdiction
CN
Classification
—
Expires
2012-10-24
Drug substance claim
No
Drug product claim
No
Assignee
Sun Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.